Lotte Biologics, a biopharmaceutical contract development and manufacturing organization (CDMO) established in 2022, is struggling to dispel concerns about its viability, as its newly nominated CEO, ...
Kelric Mullen said he and co-founder Mackenzie Salisbury will "re-evaluate" a handshake deal valuing Flashback at $5 million.